Mary Yianni, Publisher at Taylor & Francis, reviews the different models of peer review and explains the emerging role of pre-prints in biomedical sciences.

Recorded 13 June 2018 at a MedComms Networking event in Oxford. Produced by NetworkPharma.tv

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

ABSTRACT:

Taylor & Francis Group, an Informa business, publishes more than 2,500 journals and over 5,000 new books each year, offering a range of commercial services, including accelerated publishing, supplements, sponsored focus and reprints. The company recently acquired Dove Medical Press, which specialises in the publication of open access journals across the broad spectrum of science, technology and especially medicine. This presentation highlights the crucial role peer review plays in scholarly publication.

Publishers are finding reviewer selection increasingly challenging and new initiatives for reviewer credit and incentives are emerging to encourage academics to peer review papers. Alongside this, new models of peer review are becoming more commonplace.

Double-blind peer review, where neither the author nor the reviewer names are revealed to each other, remains the most common model of peer review. Open peer review, where all identities are known, can be seen to encourage accountability, civility and quality, and has emerged in recent years as an alternative model and used particularly effectively in sound science journals. Some positives and negatives of these models along with other models of peer review are discussed.
Very much adjacent to the topic of peer review is that of the pre-print, defined as a version of a scholarly or scientific paper that precedes publication in a peer-reviewed scholarly or scientific journal. This presentation discusses the upcoming launch of medRxiv alongside the perceived benefits of pre-prints. Concerns raised at the US International Society for Medical Publication Professionals (ISMPP) meeting, 2018, are also covered, as is the publisher’s perspective.

Written by Mary Yianni, Publisher at Taylor & Francis

= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =

We are building a library of free webcasts, like this one, for the global MedComms Community and others at http://www.networkpharma.tv and we’d welcome your suggestions for new topics and speakers.

Full details of this MedComms Networking event are at http://medcommsnetworking.com/event_130618.html

Mary’s presentation (PDF format) is at http://medcommsnetworking.com/presentations/yianni_130618.pdf

Mary’s Linkedin page is at https://www.linkedin.com/in/mary-yianni-b689a64a/

More about Taylor & Francis can be found at http://taylorandfrancis.com/

Filming and technical direction by Mario Crispino, Freelance Cameraman & Editor

Editorial support by Penny Gray, Freelance Medical Writer

[For the avoidance of doubt: this video is intended to be freely accessible to all. Please feel free to share and use however you like. Cheers Peter Llewellyn, Director NetworkPharma Ltd and Founder of the MedComms Networking Community activity at http://www.medcommsnetworking.com]